KeyBanc analyst Matthew Gillmor reiterated an Overweight rating and $185.00 price target on Tenet Healthcare (NYSE: THC).The analyst commented: "Policy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Tenet Healthcare (THC) PT Lowered to $185 at Raymond James, 'Selloff After Quarter is Perplexing — Creates Attractive Entry Point Despite Policy Risks'February 13, 2025 8:45 AM